Metraipolis › archive › dc_f69e9e73f7cf

Catheter ablation versus no ablation for atrial fibrillation in cardiac amyloidosis: a propensity-matched cohort study — Europe PMC PMID:42544221

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42544221
DOI
10.21542/gcsp.2026.26
License (as archived)
solo-consultazione
Archived
2026-10-10T01:26:26.855Z
SHA-256 of the archived text
7e1ba2735f8b40315c38fd91711e895964eaa8696d4599f31ffde33b26d9bead
Stable URL of this page
https://metraipolis.com/documento/dc_f69e9e73f7cf

How to cite

Catheter ablation versus no ablation for atrial fibrillation in cardiac amyloidosis: a propensity-matched cohort study — Europe PMC PMID:42544221 — Europe PMC (en), https://europepmc.org/article/MED/42544221 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f69e9e73f7cf (Metraipolis archive dc_f69e9e73f7cf, sha256 7e1ba2735f8b40315c38fd91711e895964eaa8696d4599f31ffde33b26d9bead)
BibTeX
@misc{dcf69e9e73f7cf,
  title = {Catheter ablation versus no ablation for atrial fibrillation in cardiac amyloidosis: a propensity-matched cohort study — Europe PMC PMID:42544221},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42544221},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f69e9e73f7cf; sha256 7e1ba2735f8b40315c38fd91711e895964eaa8696d4599f31ffde33b26d9bead},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42544221. Agents can read the archived copy with the MCP tool read_document.